Article metrics
PDF
Other content recommended for you
- Parkinson’s disease: etiopathogenesis and treatment
- Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease
- Deep brain stimulation for movement disorders
- Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson’s disease patients previously reliant on apomorphine
- Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
- Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation
- Emergencies and critical issues in Parkinson’s disease
- Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease
- A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up
- Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson’s disease: target related effect or selection bias?